The ‘Ozempic effect’ is weighing on gym stocks. But it could turn out to be a boom for the industry

16,Nov,2023 | Investment | 0 comments

An analyst says the "gut reaction" that Ozempic and other GLP-1 medications are bad for gyms appears to be "increasingly falling by the wayside." Originally published at CNBC

Submit a Comment

Your email address will not be published. Required fields are marked *

Small Business Minder
error: Content is protected !!